• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Catalog Number BXA075901J
Device Problem Deformation Due to Compressive Stress (2889)
Patient Problem Occlusion (1984)
Event Date 06/17/2020
Event Type  malfunction  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.(b)(4).
 
Event Description
Following was reported to gore: in (b)(6), 2020, a patient underwent endovascular treatment of in-stent restenosis of the left common iliac artery using gore® viabahn® vbx balloon expandable endoprosthesis(vbx).The procedure was completed without any issues.Date unknown, it was confirmed that the vbx was compressed and was occluded by thrombosis.On (b)(6) 2020, reintervention placing two bare metal stents was performed.The intraoperative imaging confirmed blood flow, and the procedure was completed.After few days from the re-intervention of placing two bare metal stents, it was revealed the vbx was compressed again.Femoral-femoral bypass was performed.The patient tolerated the procedure.The physician reported that since the patient has scoliosis and a kyphotic spine, the vbx in the common iliac artery became externally compressed.After f-f bypass, the patient was doing well.
 
Manufacturer Narrative
H6.Results code 2: 213: engineering evaluation: the referenced complaint did not have a returned device.The following evaluation is based on information obtained from the event description and communication summary.Crush resistance of the vbx device can be influenced by the stent ring material, stent ring geometry, stent ring spacing, and stent ring alignment.The stent rings are certified by the supplier for the material and geometric properties.Stent rings are 100% verified during the manufacturing process to be free of visual deformities.Stent ring geometry, spacing, and alignment are 100% verified during the manufacturing process.The device history file was reviewed, and no anomalies were identified.Machine history files were reviewed, and no non-routine maintenance was identified.Based on the device evaluation performed, no manufacturing anomalies were identified to which the event could be definitively attributed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10568069
MDR Text Key207992106
Report Number2017233-2020-01279
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 03/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/14/2022
Device Catalogue NumberBXA075901J
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/26/2020
Initial Date FDA Received09/22/2020
Supplement Dates Manufacturer Received03/22/2021
Supplement Dates FDA Received03/30/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age90 YR
-
-